Evidence map›Paper›PMID 27053209›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2016

Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease.

Sarah Y Branch, Cang Chen, Ramaswamy Sharma, James D Lechleiter, Senlin Li, Michael J Beckstead

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Frontiers in neuroscience · 2025
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Chronobiology of Parkinson's disease: Past, present and future.The European journal of neuroscience · 2023
    Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Sarah Y BranchDepartments of Physiology.
Cang ChenMedicine.
Ramaswamy SharmaCellular and Structural Biology, and.
James D LechleiterCellular and Structural Biology, and.ORCID http://orcid.org/0000-0001-9000-0722
Senlin LiMedicine, Center for Biomedical Neuroscience, University of Texas Health Science Center, San Antonio, Texas 78229 beckstead@uthscsa.edu Lis1@uthscsa.edu.
Michael J BecksteadDepartments of Physiology, Center for Biomedical Neuroscience, University of Texas Health Science Center, San Antonio, Texas 78229 beckstead@uthscsa.edu Lis1@uthscsa.edu.
Institut de Biologie Moléculaire et Cellulaire · FRThe University of Texas Health Science Center at San Antonio · USCzech Academy of Sciences, Institute of Physiology · CZImmunovaccine (Canada) · CA

Funding

Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR001120 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, HARGREAVES, KENNETH M · 2013 to 2017
$16.5M
The role of dendrodendritic dopamine neurotransmission in methamphetamine abuseR01DA032701 · NIDA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BECKSTEAD, MICHAEL J · 2013 to 2017
$1.7M
NCATS NIH HHS UL1 TR001120NIDA NIH HHS R01 DA032701NIDA NIH HHS R01 DA32701
6 · The paper itself

Abstract

Dopaminergic neurons of the substantia nigra (SN) play a vital role in everyday tasks, such as reward-related behavior and voluntary movement, and excessive loss of these neurons is a primary hallmark of Parkinson's disease (PD). Mitochondrial dysfunction has long been implicated in PD and many animal models induce parkinsonian features by disrupting mitochondrial function. MitoPark mice are a recently developed genetic model of PD that lacks the gene for mitochondrial transcription factor A specifically in dopaminergic neurons. This model mimics many distinct characteristics of PD including progressive and selective loss of SN dopamine neurons, motor deficits that are improved byl-DOPA, and development of inclusion bodies. Here, we used brain slice electrophysiology to construct a timeline of functional decline in SN dopaminergic neurons from MitoPark mice. Dopaminergic neurons from MitoPark mice exhibited decreased cell capacitance and increased input resistance that became more severe with age. Pacemaker firing regularity was disrupted in MitoPark mice and ion channel conductances associated with firing were decreased. Additionally, dopaminergic neurons from MitoPark mice showed a progressive decrease of endogenous dopamine levels, decreased dopamine release, and smaller D2 dopamine receptor-mediated outward currents. Interestingly, expression of ion channel subunits associated with impulse activity (Cav1.2, Cav1.3, HCN1, Nav1.2, and NavB3) was upregulated in older MitoPark mice. The results describe alterations in intrinsic and synaptic properties of dopaminergic neurons in MitoPark mice occurring at ages both before and concurrent with motor impairment. These findings may help inform future investigations into treatment targets for prodromal PD. SIGNIFICANCE STATEMENT: Parkinson's disease (PD) is the second most diagnosed neurodegenerative disorder, and the classic motor symptoms of the disease are attributed to selective loss of dopaminergic neurons of the substantia nigra. The MitoPark mouse is a genetic model of PD that mimics many of the key characteristics of the disease and enables the study of progressive neurodegeneration in parkinsonism. Here we have identified functional deficits in the ion channel physiology of dopaminergic neurons from MitoPark mice that both precede and are concurrent with the time course of behavioral symptomatology. Because PD is a progressive disease with a long asymptomatic phase, identification of early functional adaptations could lay the groundwork to test therapeutic interventions that halt or reverse disease progression.

Indexed as

AgingAnimalsBiological ClocksDendritesDNA-Binding ProteinsDopaminergic NeuronsElectric CapacitanceElectrophysiological PhenomenaFemaleIon ChannelsMaleMiceMice, Inbred C57BLMitochondrial ProteinsNeural ConductionParkinson DiseaseDNA-Binding ProteinsIon ChannelsMitochondrial Proteinsmitochondrial transcription factor ATranscription FactorsdopamineelectrophysiologymiceMitoParkneurotransmissionParkinson's

Identifiers

PMID27053209
PMCPMC4821912
OpenAlexW2313304154

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.